ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 955,44
0,52%
Dow Jones
38 659,38
1,13%
DAX
17 996,45
0,51%
Brent Oil
83,235
-0,47%
Bitcoin
61 580,68
4,16%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Phathom Pharmaceuticals Inc (PHAT)

  7. Phathom Pharmaceuticals Inc (PHAT) Actualités

PHAT Phathom Pharmaceuticals Inc

10,05
0,29 (2,97%)
Dernière mise à jour : 17:26:35
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Phathom Pharmaceuticals Inc PHAT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,29 2,97% 10,05 17:26:35
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
10,35 9,88 10,37 9,76
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202414:00GLOBEPhathom Pharmaceuticals to Report First Quarter 2024..
03/4/202414:00GLOBEPhathom Pharmaceuticals to Participate in the 23rd Annual..
26/3/202413:00GLOBEPhathom Pharmaceuticals Launches Direct-to-Consumer..
07/3/202422:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202414:06EDGAR2Form 8-K - Current report
07/3/202414:00GLOBEPhathom Pharmaceuticals Reports Fourth Quarter and Full Year..
29/2/202414:00GLOBEPhathom Pharmaceuticals to Report Fourth Quarter and Full..
13/2/202414:05EDGAR2Form 8-K - Current report
13/2/202414:00GLOBEPhathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan)..
31/1/202414:00GLOBEPhathom Pharmaceuticals to Present at the Guggenheim..
23/1/202402:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:05EDGAR2Form 8-K - Current report
14/12/202314:05EDGAR2Form 8-K - Current report
14/12/202314:00GLOBEPhathom Pharmaceuticals Announces Expansion of Existing Loan..
06/12/202314:05EDGAR2Form 8-K - Current report
06/12/202314:00GLOBEPhathom Pharmaceuticals Announces FDA Acceptance for Filing..
28/11/202314:06EDGAR2Form 8-K - Current report
28/11/202314:00GLOBEPhathom Pharmaceuticals Announces Commercial Availability of..
20/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
09/11/202322:02EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202314:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202314:05EDGAR2Form 8-K - Current report
09/11/202314:00GLOBEPhathom Pharmaceuticals Reports Third Quarter 2023 Results..
09/11/202301:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202322:50DJNPhathom Pharmaceuticals Gets FDA Approval for Voquezna..
01/11/202322:06EDGAR2Form 8-K - Current report
01/11/202322:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®..
30/10/202313:05EDGAR2Form 8-K - Current report
30/10/202313:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of..
25/10/202314:01GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
26/9/202314:05EDGAR2Form 8-K - Current report
26/9/202314:01GLOBEPhathom Pharmaceuticals Announces Vonoprazan NDA Submission..
05/9/202314:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
21/8/202314:07EDGAR2Form 8-K - Current report
21/8/202314:00GLOBEPhathom Pharmaceuticals Announces Submission of Six-Month..
10/8/202322:02EDGAR2Form 8-K - Current report
10/8/202314:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:01GLOBEPhathom Pharmaceuticals Reports Second Quarter 2023 Results
17/7/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202322:04EDGAR2Form 8-K - Current report
17/7/202322:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
12/6/202315:04DJNFDA Accepts Phathom Pharmaceuticals' Resubmission for..
12/6/202314:01GLOBEPhathom Pharmaceuticals Announces FDA Acceptance of NDA..
09/6/202322:01GLOBEPhathom Pharmaceuticals Announces Closing of Underwriters’..
09/6/202311:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
07/6/202311:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
02/6/202311:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
01/6/202314:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
30/5/202311:00PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..

Dernières Valeurs Consultées

NASDAQ
PHAT
Phathom Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés